DR. JOSEPH SLIWKOWSKI
President/Co-Founder GIVE Inc.
Exceeding Expectations and Improving Healthcare Delivery with Blockchain
At GIVE mHealth, we provide our patients with access to state-of-the-art healthcare delivery along with the most experienced and dedicated healthcare professionals. In 2014, GIVE Inc. established the concept of conducting clinical trials through a mobile health platform. Since then, our mission has been to provide quality global healthcare delivery through a mobile platform.
By applying artificial intelligence, we are now making that possible through the GIVE Health Blockchain.
From Nutrition Consultations to Pediatric Check-Ups , our personalized mobile health services allow us to manage whatever health concern our patients might have and empower patients with a blockchain mobile health solution. Book an appointment today and see what we can do for you or your loved ones.
Here’s What’s Happening
GIVE MHEALTH BLOCKCHAIN
The GIVE mHealth medical team led the conducting of global medical missions to developing countries. Whether monitoring patients on how to stay healthy, or want to learn about the latest healthcare trends, our mHealth Pilot Program is always accessible and regularly updated to include the most relevant information.
REMOTE MHEALTH CLINICAL TRIALS LEADING TO BETTER MEDICAL OUTCOMES
October, 26, 2016
Dr. John Mattison Chief Medical Information Officer of Kaiser Permanente, Dr. Andrew Ellner, the Director of Global Primary Care at Harvard Medical School, and Reginald Mbawuike, Harvard Information Technology Fellow led the way presenting the expansive intricacies in the problems facing doctors and patients and medical technology solutions. The GIVE mHealth Pilot Program was presented as a series of clinical trials that aim to lead to an elimination of these health disparity gaps. This distinctive global health platform has been established to be patient-driven focused.
CONDUCTING CLINICAL TRIALS WITH GIVE MHEALTH
August 30, 2017
GIVE mHealth clinical trial program focuses on increasing access for patients connecting digital diagnostics through remote areas across the world. Utilizing artificial intelligence and medical expertise in global health equity to improve healthcare access in distant regions around the world is the aim of the clinical trial program. The advancement of artificial intelligence has enabled devices to monitor and examine people’s body vital functions remotely in distant areas, a vast advancement over early health monitoring devices. The clinical trial program examines how to utilize this technology in the US to improve healthcare access.
A LOOK AT THE INDUSTRY’S LATEST MEDICAL TECHNOLOGIES
September, 27, 2018
The GIVE mHealth Forum brings mobile health, artificial intelligence, blockchain and other digital diagnostics developers to the Harvard Faculty Club to meet individually with the leaders of the life sciences sector led by Medical Doctors and Fellows from Harvard University and the medical industry. This distinctive global health platform is mHealth industry focused with New England life sciences region as central hub. The event was held at the Harvard Faculty Club led by chief executives and lead doctors from Kaiser Permanente, Harvard Medical School, and Health Innovators.
Last year the Chief Medical Officer, the Medical Director and the Founder of GIVE Inc. were highlighted at the United Nations where they presented mobile health and its place in improving pelvic related illnesses and maternal mortality. During the United Nations General Assembly they returned to the UN with an event led by GIVE Inc's Head of AI and the former Chief Technology Officer of IBM Mark Minevich. Here, we brought together stakeholders from global finance, blockchain CEOs, heads of state and foreign ministers, and the United Nations to financing global health solutions. To be a part of next year’s event as a sponsor contact us at Doctors@GIVEmHealthGlobal.com.